SPC3: COB began Phase I/II testing of SPC3.

Columbia Laboratories Inc. (COB), Miami, Fla. Product: SPC3, blocker of HIV entry through co-receptors to CD4 Indication: HIV Status: COB began Phase I/II testing of SPC3. The compound mimics the part...